The synthesis and antimicrobial activity of some 4-hydroxycoumarin derivatives

被引:21
作者
Zavrsnik, Davorka [1 ]
Muratovic, Samija [1 ]
Spirtovic, Selma [1 ]
Softic, Dzenita [2 ]
Medic-Saric, Marica [3 ]
机构
[1] Univ Sarajevo, Fac Pharm, Dept Pharmaceut Chem, Sarajevo 71000, Bosnia & Herceg
[2] Inst Qual Control Med, Sarajevo 71000, Bosnia & Herceg
[3] Univ Zagreb, Dept Pharmaceut Chem, Fac Pharm & Biochem, Zagreb 10000, Croatia
关键词
dimers; tetramers; derivatives of 4-hydroxycoumarin; antimicrobial activity; minimal inhibition concentration; MIC; minimal bactericidal concentration; MBC;
D O I
10.17305/bjbms.2008.2933
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Due to exceptional reactivity Of 4-hydroxycoumarin, the synthesis of new coumarin derivatives of dimer and tetramer type has been carried out. The synthesis was carried out from 4-hydroxycoumarin and various aromatic aldehydes. In this way, compounds of the dimer 3,3'-(benzilidene)bis (4-hydroxycoumarin) type, as well as of the tetramer 3,3 3,3'"-(1,4-dimthylphenyl)tetra (4-hydroxycoumarin) type were prepared. The newly synthesized derivatives contain different functional groups, and as Such they could exhibit microbiological activity, Therefore, we tested the microbiological activity of these derivatives on various species of bacteria and fungi. The tested compounds have shown different activity in terms of growth inhibition of microorganisms. Newly synthesized derivatives exhibit antibacterial activities, manifested as growth inhibition on Grampositive bacteria types (Bacillus, Staphylococcus), while the activity against Candida was much weaker. The same compound did not show any antimicrobial activity against two Gram-negative bacteria types (Escherichia coli, Pseudomonas aeruginosa). The compound 1 showed the best microbiological activity. The obtained results confirmed its good antibacterial and antimycotic activities against different microorganisms.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 11 条
[1]  
BOSIGNORE L, 1998, FARMACO, V30, P425
[2]  
*COUNC EUR PARL, 2004, EUR PHARM S, P95
[3]   A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome [J].
Crowther, MA ;
Ginsberg, JS ;
Julian, J ;
Denburg, J ;
Hirsh, J ;
Douketis, J ;
Laskin, C ;
Fortin, P ;
Anderson, D ;
Kearon, C ;
Clarke, A ;
Geerts, W ;
Forgie, M ;
Green, D ;
Costantini, L ;
Yacura, W ;
Wilson, S ;
Gent, M ;
Kovacs, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) :1133-1138
[4]   Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities [J].
Fylaktakidou, KC ;
Hadjipavlou-Litina, DJ ;
Litinas, KE ;
Nicolaides, DN .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) :3813-3833
[5]  
Gürsoy A, 2003, TURK J CHEM, V27, P545
[6]   Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: A phase 2 study [J].
Hahm, HA ;
Armstrong, DK ;
Chen, TL ;
Grochow, L ;
Passos-Coelho, J ;
Goodman, SN ;
Davidson, NE ;
Kennedy, MJ .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) :335-343
[7]  
Kayser O, 1999, Z NATURFORSCH C, V54, P169
[8]   Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer [J].
Lacy, A ;
O'Kennedy, R .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) :3797-3811
[9]   Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease [J].
Mazumder, A ;
Wang, SM ;
Neamati, N ;
Nicklaus, M ;
Sunder, S ;
Chen, J ;
Milne, GWA ;
Rice, WG ;
Burke, TR ;
Pommier, Y .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (13) :2472-2481
[10]   Synthesis and antifungal activity of coumarins and angular furanocoumarins [J].
Sardari, S ;
Mori, Y ;
Horita, K ;
Micetich, RG ;
Nishibe, S ;
Daneshtalab, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (09) :1933-1940